The new RPQure Neuromedical Genetics website is up and running to inform about progress in retinal gene therapy, especially on retinitis pigmentosa and Leber congenital amaurosis due to mutations in the CRB1 gene.

The RPQure website will inform you about new developments and progress on the generation of AAV CRB1 gene therapy.